Cargando…
Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732229/ http://dx.doi.org/10.1007/s40278-022-08160-y |
Ejemplares similares
-
Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Publicado: (2022) -
Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022) -
Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021) -
Rituximab: Hypogammaglobulinaemia: 2 case reports
Publicado: (2021) -
Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
por: Daniel, Jefferson, et al.
Publicado: (2021)